Fingerprint
Dive into the research topics of 'AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019
the COVID-19 Study to Optimally Reduce Morbidity in CareHomes and Sites with Enhanced Risk (STORMCHASER) Study Group
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations